Clinical Trials
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Agenus Receives Merck Milestone
After Merck's initiation of a Phase I clinical trial of an undisclosed antibody candidate discovered by Agenus08.16.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Industry News | R&D
Altasciences Acquires SNBL's Preclinical Testing Business
Will add comprehensive preclinical safety testing services to Altasciences’ full service clinical and bioanalytical offerings08.15.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Mustang Bio, St. Jude Partner for X-SCID
Most common form of severe combined immunodeficiency, affecting approximately one in 50,000 to 100,000 newborns worldwide08.13.18
-
Bio News | Clinical Trials | Drug Development | Drug Discovery | Industry News | R&D | Trials & Filings
Denali Announces Positive Phase I Study Results
The study involved DNL201, a small molecule inhibitor of leucine-rich repeat kinase 208.03.18
-
Bio News | Clinical Trials | Drug Development | Industry News | R&D | Trials & Filings
Theravance Announces Positive Phase II Results
For TD-9855, a once-daily norepinephrine & serotonin reuptake inhibitor in development for treatment of symptomatic nOH08.01.18
-
Bio News | Clinical Trials | Drug Development | Industry News | Trials & Filings
Athenex Announces Positive Phase 3 Endpoints
Both studies, KX-AK-003 and KX-AK-004, had achieved their primary endpoint of 100% clearance of actinic keratosis lesions07.26.18
-
Clinical Trials | CRO News | Information Technology
PPD Expands Central Labs’ Preclarus Technology
Features new client portal, functionality improvements, investigator site portal and a new companion mobile app07.25.18
-
Clinical Trials | Collaborations & Alliances | Industry News | R&D
Takeda, Ovid Detail Clinical Development Program
The companies plan to initiate three clinical trials to investigate the potential of TAK-935/OV93507.18.18
-
Bio News | Clinical Trials | Industry News | R&D
Roche Phase III Study Meets Primary Objective
Assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications from the flu07.17.18
-
Clinical Trials | Drug Development | Industry News | Information Technology
CluePoints, ONO in Four-Year RBM Pact
ONO will utilize CluePoints’ centralized statistical monitoring platform07.13.18
-
Analytical Services | Bio News | Breaking News | Clinical Trials | CRO News | Drug Discovery | Laboratory Testing
Streamlining the Clinical Process
Richard Young, vice president at Veeva, shares insight on what companies can do to further expedite the clinical processOnline Exclusives07.12.18
-
Clinical Trials | Drug Development | Regulatory Affairs
Are EMA-Style Rules for First-in-Human Trials Coming to North America?
Insights from the 2018 DIA Global MeetingBeatrice Setnik, Ph.D., Vice President, Scientific and Clinical Strategy, Early Phase, Syneos Health 07.03.18
-
Clinical Trials | Drug Development | Industry News | Information Technology | R&D
Sanofi Launches Global R&D Ops in China
New global R&D operations hub focused on digitalization and big data analysis07.02.18
-
Clinical Trials | Collaborations & Alliances | Industry News
Kymab, Roche Partner to Evaluate KY1044
Roche to provide PD-L1 blocking antibody atezolizumab in combination in Kymab’s upcoming Phase I-II clinical studies06.28.18
-
Clinical Trials | Drug Development | Information Technology
Report Reveals Drug Development Innovations Positively Impact Trial Timelines
Adaptive, patient-centric, precision medicine, and real-world data trials increase likelihood of market launch by 10-21%06.25.18
-
Clinical Trials | CRO News | Information Technology
ICON Enhances Endpoint Adjudication Services
Will leverage AG Mednet's comprehensive electronic endpoint adjudication system06.11.18
-
Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery
GE, XPH Enter FlexFactory Agreement
To scale up, digitize & accelerate manufacturing processes for their cell therapy clinical trials & future commercialization06.07.18
-
Clinical Trials | Drug Development | Industry News | Information Technology
Ready for ASCO
Why ASCO’s annual meeting is one of the most important events in the oncology communityDr. Eric Groves, Vice President of Strategic Drug Development, R&D Solutions, IQVIA 06.01.18
-
Clinical Trials | CRO News | Laboratory Testing
ACM Global Labs Adds New Testing Services for Oncology Trials
Introduces therapeutic service offering to support the specific testing needs of oncology clinical trials06.01.18
-
Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
PPD and NeoGenomics Form Global Strategic Alliance
Expanding global oncology testing for clinical trials06.01.18
